Jack Lichtenstein
Internal Medicine · Annapolis, MDNPI 1609844224
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,805 of the $13,805 with a category attached, or 85.5%. It is spread thinly across 34 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $4,036 and has fallen 99.2% since, to $31 in 2023. Among internal medicine clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 716 payments — averaging $19.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- Pfizer$2K
- AbbVie$2K
- Johnson & Johnson$945
- Novartis$856
- UCB, Inc.$764
- plus $4K from 28 others
What the payments were for
- Consulting fees$1,85013%
- Food & beverage$11,80586%
- Education$1511%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 175 | $2,903 |
| Pfizer | 30 | $2,336 |
| AbbVie(2 entities) | 119 | $1,708 |
| Johnson & Johnson(2 entities) | 52 | $945 |
| Novartis | 55 | $856 |
| UCB, Inc. | 41 | $764 |
| Lilly USA, LLC | 55 | $757 |
| E.r. Squibb & Sons, L.L.C. | 41 | $581 |
| Mallinckrodt Hospital Products Inc. | 15 | $356 |
| Mallinckrodt Enterprises LLC | 15 | $347 |
| Aurinia Pharma U.S., Inc. | 9 | $268 |
| Antares Pharma, Inc. | 17 | $259 |
| Radius Health, Inc. | 12 | $223 |
| Genentech USA, Inc. | 4 | $163 |
| CSL Behring | 8 | $151 |
| Bristol Myers Squibb | 9 | $151 |
| GSK | 9 | $149 |
| AstraZeneca | 9 | $139 |
| Regeneron Healthcare Solutions, Inc. | 6 | $119 |
| Sobi, Inc | 5 | $112 |
| Bio Products Laboratory USA, Inc. | 5 | $100 |
| Pacira Therapeutics, Inc. | 6 | $94 |
| Boehringer Ingelheim | 3 | $74 |
| Hikma Pharmaceuticals USA | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 3 | $39 |
| Actelion Pharmaceuticals US, Inc. | 1 | $38 |
| Biodelivery Sciences International, Inc. | 2 | $23 |
| Oxford Immunotec USA Inc | 1 | $21 |
| Eisai Inc. | 1 | $19 |
| Merck | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Medexus Pharma, Inc. | 1 | $12 |
| Zimmer Biomet | 1 | $11 |
| Organon | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XELJANZ$1,850
How this compares
$13,805 in reported general payments places this provider in the 95th percentile of 2,979 internal medicine providers in Maryland.
Other internal medicine in Annapolis
- Brian HarveyAnnapolis$220K
- Aditya ChopraAnnapolis$85K
- Marianne MannHighland$2.1M
- Param DedhiaBaltimore$636K
- Curtis RosebraughAshton$418K
- Mark CorriereColumbia$402K
- Gregory PokrywkaTowson$377K
- Shawn DhillonBaltimore$227K
- Jeremy SugarmanBaltimore$210K
- Florence HounPotomac$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.